Source material behind every call on the tape.
Modern mines have some disconnect. The hardware is already there. Cameras on haul roads. Drones doing survey flights. GPS on every truck. Thermal imaging. Conveyor monitors. Stockpile cameras. The site is already covered in devices that capture information. It just …
41% interest the storm is on the horizon the thing we need is a catalyst. Options expire on Friday with just a little nudge up to $7.50 this would let so many calls be in the market. Regardless of news …
I know this is probably an unpopular take, but I think the market is massively overestimating Anthropic’s moat. Bloomberg is reporting that DeepSeek is already preparing for an IPO after reportedly raising at around a $71B valuation, and they got …
Before the loss my total yolo was \~$10k. Mods, if you need me to post all 11 positions individually in the comments just let me know. This is both a YOLO and discussion post. While I’m not going to lay …
I’m traditionally a long term investor, but I’m getting into swing trading to pursue more aggressive account growth. I primarily use ThinkorSwim for trading insights, but just curious what other folks are using? I’m interested in tools for: \- research …
[removed]
I noticed that the same PAX/USDT pair currently appears across three Uniswap V3 pools with very different displayed prices. One pool shows around $0.34, another around $0.92, and a very small pool shows around $0.968. My understanding is that each …
AnaptysBio (ANAB) isn’t your traditional biotech play. Essentially, it is a low-overhead royalty-management company formed around 2 drugs: Jemperli (partnered with GSK) and imsidolimab (partnered with Vanda Pharma). Here’s the relevant backstory. In 2014, ANAB signed a collaboration and exclusive …